Advertisement
Screener

Standard BioTools Inc. (LAB) Material Contracts, 2025

Standard BioTools Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2025-08-15: Form 10-Q; Exhibit 10.1; Description Omnibus Amendment Re Collaboration Agreement, by and among Illumina Cambridge, Ltd., SomaLogic, Inc. and Illumina, Inc..
  • 2025-06-20: Form 8-K; Exhibit 10.1; Description Standard BioTools Inc. Amended and Restated 2011 Equity Incentive Plan, as Amended..
  • 2025-03-11: Form 10-K; Exhibit 10.38; Description Sean Mackay Offer Letter..
FiledFormExhibitDescription
2025-08-1510-Q10.1Omnibus Amendment Re Collaboration Agreement, by and among Illumina Cambridge, Ltd., SomaLogic, Inc. and Illumina, Inc.
2025-06-208-K10.1Standard BioTools Inc. Amended and Restated 2011 Equity Incentive Plan, as Amended.
2025-03-1110-K10.38Sean Mackay Offer Letter.

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01